Anqiu Lu'an Pharmaceutical Co., Ltd., commonly referred to as Lu'an Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in Anqiu, Shandong Province, China. Established in 1996, the company has made significant strides in the development and production of traditional Chinese medicine and modern pharmaceuticals, focusing on areas such as cardiovascular health, anti-infectives, and pain management. With a commitment to quality and innovation, Lu'an Pharmaceutical offers a diverse range of core products, including herbal extracts and chemical drugs, which are distinguished by their efficacy and safety. The company has achieved notable market recognition, positioning itself as a trusted name in both domestic and international markets. Through continuous research and development, Anqiu Lu'an Pharmaceutical remains dedicated to advancing healthcare solutions and improving patient outcomes.
How does Anqiu Lu'an Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Anqiu Lu'an Pharmaceutical's score of 5 is lower than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Anqiu Lu'an Pharmaceutical, headquartered in CN, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Anqiu Lu'an Pharmaceutical may not have established formal commitments to address carbon emissions or climate change initiatives at this time. As the pharmaceutical industry increasingly focuses on sustainability, it is essential for companies like Anqiu Lu'an to consider developing and communicating their climate strategies to align with global standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Anqiu Lu'an Pharmaceutical has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
